EVALUATION OF BLOOD BIOMARKER-BASED DIAGNOSTIC AID IN OUTPATIENTS SUFFERING FROM DEPRESSION
This study is completed. It focuses on depression and currently lists study information in Switzerland.
In Switzerland
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on depression and currently lists study information in Switzerland.
In SwitzerlandThis study is completed. It focuses on depression and currently lists study information in Switzerland.
In SwitzerlandThis study is completed. It focuses on mental health and currently lists study information in Switzerland.
In SwitzerlandThis study is completed. It focuses on mental health and currently lists study information in Switzerland.
In SwitzerlandThis study is enrolling by invitation. It focuses on depression and currently lists participation information in Switzerland.
Remote / onlineThis study is completed. It focuses on bipolarity and currently lists study information in Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, the Netherlands, Serbia and Montenegro, Spain, Sweden, Switzerland, and the United States.
In SwitzerlandThis study is completed. It focuses on schizophrenia and currently lists study information in Switzerland.
In SwitzerlandThis study is completed. It focuses on ADHD and currently lists study information in Switzerland.
In SwitzerlandThis study has public registry information. It focuses on ADHD and currently lists study information in Switzerland.
In SwitzerlandThis study is completed in France, in Switzerland, in Germany, .... It is testing Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate for ADHD.
In SwitzerlandThis study is completed. It focuses on schizophrenia and currently lists study information in Switzerland.
In SwitzerlandThis study has public registry information. It focuses on schizophrenia and currently lists study information in Switzerland.
In Switzerland